Amgen (AMGN) Return on Capital Employed [ROCE] (2009 - 2026)
Amgen (AMGN) reported Return on Capital Employed [ROCE] of 16.66% for Q2 2026, up 4.64 percentage points from 12.02% a year earlier and up 0.79 percentage points from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, Amgen posted Return on Capital Employed [ROCE] of 13.82%, up 3.65 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a five-year change of -4.58 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at 10.17% in FY2024 (-2.42 pp), 12.59% in FY2023 (-7.57 pp), 20.16% in FY2022 (+4.84 pp) and 15.32% in FY2021 (-3.08 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2022.
- Year over year, Return on Capital Employed [ROCE] has now increased in each of the last seven quarters, with an average year-over-year change of +2.36 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2022 (a gain of 4.99 percentage points); the low point was Q4 2023 (a drop of 9.17 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 15.87% (Q1 2026), 14.00% (Q4 2025) and 12.90% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 20.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.66% |
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | 14.00% |
| Sep 30, 2025 | 12.90% |
| Jun 30, 2025 | 12.02% |
| Mar 31, 2025 | 11.01% |
| Dec 31, 2024 | 10.63% |
| Sep 30, 2024 | 8.81% |
| Jun 30, 2024 | 8.79% |
| Mar 31, 2024 | 9.25% |
| Dec 31, 2023 | 10.47% |
| Sep 30, 2023 | 12.06% |
| Jun 30, 2023 | 13.12% |
| Mar 31, 2023 | 14.33% |
| Dec 31, 2022 | 19.63% |
| Sep 30, 2022 | 20.44% |
| Jun 30, 2022 | 20.07% |
| Mar 31, 2022 | 16.94% |
| Dec 31, 2021 | 15.01% |
| Sep 30, 2021 | 15.45% |
API Access
Amgen Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();